Langerhans cell histiocytosis shows distinct cytoplasmic expression of major histocompatibility class II antigens

Lucas Redd, Monika Schmelz, W. Richard Burack, James R. Cook, Antony W. Day, Lisa Rimsza

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Langerhans cell histiocytosis (LCH) is a monoclonal proliferation of antigen presenting cells (APC). In benign APCs, antigen loading occurs in the major histocompatibility class II (MHCII)-lysosomal compartment of the endocytic pathway followed by transport to the cell surface upon antigen stimulation. The pattern of MHCII expression in LCH is not well characterized. The cellular localization of MHCII was determined using immunohistochemistry (IHC). Staining pattern for the representative MHCII molecule, HLA-DR, (cell surface, cytoplasmic granular, or cytoplasmic globular), and intensity (0 to 3+) was recorded for normal tissues and 44 LCH samples along with available clinicopathologic features. Results were confirmed with a different antibody to confirm the appearance. In the normal tissue survey, strong HLA-DR cell surface expression was present on APCs, benign B cells, and some T cells. A granular cytoplasmic staining pattern (without surface expression) was seen in benign Langerhans cells (LCs) in the skin and histiocytes. Strikingly, all 44 LCH samples demonstrated both cytoplasmic granular and an unusual “globular” staining pattern with no surface staining. This is the first report of a highly specific HLA-DR staining pattern in LCH detected by IHC. The cytoplasmic perinuclear globular localization of MHCII may possibly be useful in diagnostics and may result from an immature/antigen-naïve differentiation state of the neoplastic cell.

Original languageEnglish (US)
Pages (from-to)107-112
Number of pages6
JournalJournal of Hematopathology
Volume9
Issue number3
DOIs
StatePublished - Sep 1 2016

Fingerprint

Langerhans Cell Histiocytosis
Histocompatibility
Histocompatibility Antigens Class II
Staining and Labeling
HLA-DR Antigens
Immunohistochemistry
Histiocytes
Langerhans Cells
Differentiation Antigens
Antigen-Presenting Cells
Surface Antigens
B-Lymphocytes
T-Lymphocytes
Antigens
Skin
Antibodies

Keywords

  • HLA-DR
  • Immunophenotype
  • Langerhans cell histiocytosis
  • Major histocompatibility class II

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Histology
  • Hematology

Cite this

Langerhans cell histiocytosis shows distinct cytoplasmic expression of major histocompatibility class II antigens. / Redd, Lucas; Schmelz, Monika; Burack, W. Richard; Cook, James R.; Day, Antony W.; Rimsza, Lisa.

In: Journal of Hematopathology, Vol. 9, No. 3, 01.09.2016, p. 107-112.

Research output: Contribution to journalArticle

Redd, Lucas ; Schmelz, Monika ; Burack, W. Richard ; Cook, James R. ; Day, Antony W. ; Rimsza, Lisa. / Langerhans cell histiocytosis shows distinct cytoplasmic expression of major histocompatibility class II antigens. In: Journal of Hematopathology. 2016 ; Vol. 9, No. 3. pp. 107-112.
@article{a339508144cd45f3920986ad0d5f1626,
title = "Langerhans cell histiocytosis shows distinct cytoplasmic expression of major histocompatibility class II antigens",
abstract = "Langerhans cell histiocytosis (LCH) is a monoclonal proliferation of antigen presenting cells (APC). In benign APCs, antigen loading occurs in the major histocompatibility class II (MHCII)-lysosomal compartment of the endocytic pathway followed by transport to the cell surface upon antigen stimulation. The pattern of MHCII expression in LCH is not well characterized. The cellular localization of MHCII was determined using immunohistochemistry (IHC). Staining pattern for the representative MHCII molecule, HLA-DR, (cell surface, cytoplasmic granular, or cytoplasmic globular), and intensity (0 to 3+) was recorded for normal tissues and 44 LCH samples along with available clinicopathologic features. Results were confirmed with a different antibody to confirm the appearance. In the normal tissue survey, strong HLA-DR cell surface expression was present on APCs, benign B cells, and some T cells. A granular cytoplasmic staining pattern (without surface expression) was seen in benign Langerhans cells (LCs) in the skin and histiocytes. Strikingly, all 44 LCH samples demonstrated both cytoplasmic granular and an unusual “globular” staining pattern with no surface staining. This is the first report of a highly specific HLA-DR staining pattern in LCH detected by IHC. The cytoplasmic perinuclear globular localization of MHCII may possibly be useful in diagnostics and may result from an immature/antigen-na{\"i}ve differentiation state of the neoplastic cell.",
keywords = "HLA-DR, Immunophenotype, Langerhans cell histiocytosis, Major histocompatibility class II",
author = "Lucas Redd and Monika Schmelz and Burack, {W. Richard} and Cook, {James R.} and Day, {Antony W.} and Lisa Rimsza",
year = "2016",
month = "9",
day = "1",
doi = "10.1007/s12308-016-0272-9",
language = "English (US)",
volume = "9",
pages = "107--112",
journal = "Journal of Hematopathology",
issn = "1865-5785",
publisher = "Springer Verlag",
number = "3",

}

TY - JOUR

T1 - Langerhans cell histiocytosis shows distinct cytoplasmic expression of major histocompatibility class II antigens

AU - Redd, Lucas

AU - Schmelz, Monika

AU - Burack, W. Richard

AU - Cook, James R.

AU - Day, Antony W.

AU - Rimsza, Lisa

PY - 2016/9/1

Y1 - 2016/9/1

N2 - Langerhans cell histiocytosis (LCH) is a monoclonal proliferation of antigen presenting cells (APC). In benign APCs, antigen loading occurs in the major histocompatibility class II (MHCII)-lysosomal compartment of the endocytic pathway followed by transport to the cell surface upon antigen stimulation. The pattern of MHCII expression in LCH is not well characterized. The cellular localization of MHCII was determined using immunohistochemistry (IHC). Staining pattern for the representative MHCII molecule, HLA-DR, (cell surface, cytoplasmic granular, or cytoplasmic globular), and intensity (0 to 3+) was recorded for normal tissues and 44 LCH samples along with available clinicopathologic features. Results were confirmed with a different antibody to confirm the appearance. In the normal tissue survey, strong HLA-DR cell surface expression was present on APCs, benign B cells, and some T cells. A granular cytoplasmic staining pattern (without surface expression) was seen in benign Langerhans cells (LCs) in the skin and histiocytes. Strikingly, all 44 LCH samples demonstrated both cytoplasmic granular and an unusual “globular” staining pattern with no surface staining. This is the first report of a highly specific HLA-DR staining pattern in LCH detected by IHC. The cytoplasmic perinuclear globular localization of MHCII may possibly be useful in diagnostics and may result from an immature/antigen-naïve differentiation state of the neoplastic cell.

AB - Langerhans cell histiocytosis (LCH) is a monoclonal proliferation of antigen presenting cells (APC). In benign APCs, antigen loading occurs in the major histocompatibility class II (MHCII)-lysosomal compartment of the endocytic pathway followed by transport to the cell surface upon antigen stimulation. The pattern of MHCII expression in LCH is not well characterized. The cellular localization of MHCII was determined using immunohistochemistry (IHC). Staining pattern for the representative MHCII molecule, HLA-DR, (cell surface, cytoplasmic granular, or cytoplasmic globular), and intensity (0 to 3+) was recorded for normal tissues and 44 LCH samples along with available clinicopathologic features. Results were confirmed with a different antibody to confirm the appearance. In the normal tissue survey, strong HLA-DR cell surface expression was present on APCs, benign B cells, and some T cells. A granular cytoplasmic staining pattern (without surface expression) was seen in benign Langerhans cells (LCs) in the skin and histiocytes. Strikingly, all 44 LCH samples demonstrated both cytoplasmic granular and an unusual “globular” staining pattern with no surface staining. This is the first report of a highly specific HLA-DR staining pattern in LCH detected by IHC. The cytoplasmic perinuclear globular localization of MHCII may possibly be useful in diagnostics and may result from an immature/antigen-naïve differentiation state of the neoplastic cell.

KW - HLA-DR

KW - Immunophenotype

KW - Langerhans cell histiocytosis

KW - Major histocompatibility class II

UR - http://www.scopus.com/inward/record.url?scp=84989956664&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84989956664&partnerID=8YFLogxK

U2 - 10.1007/s12308-016-0272-9

DO - 10.1007/s12308-016-0272-9

M3 - Article

C2 - 30338008

AN - SCOPUS:84989956664

VL - 9

SP - 107

EP - 112

JO - Journal of Hematopathology

JF - Journal of Hematopathology

SN - 1865-5785

IS - 3

ER -